Open Access Highly Accessed Research article

Biologic activity and safety of belimumab, a neutralizing anti-B-lymphocyte stimulator (BLyS) monoclonal antibody: a phase I trial in patients with systemic lupus erythematosus

Richard Furie*, William Stohl, Ellen M Ginzler, Michael Becker, Nilamadhab Mishra, Winn Chatham, Joan T Merrill, Arthur Weinstein, W Joseph McCune, John Zhong, Wendy Cai, William Freimuth and the Belimumab Study Group

Arthritis Research & Therapy 2008, 10:R109  doi:10.1186/ar2506

Article Metrics

12039
Total accesses


3
BioMed Central citations

Article metric FAQ

Accesses  

  • Last 30 days: 140 accesses
  • Last 365 days: 1756 accesses
  • All time: 12039 accesses

These numbers are accesses on BioMed Central websites only, and an underestimate of total usage. More information